The Impact of Early Levothyroxine Replacement in Subclinical Hypothyroidism on Glycemic Control Parameters and Quality of Life in Adult Patients

Maha Mowafy; Eman Ahmed Rushdy; Maha Rakha; Eman Elshekheiby; Saeed Soliman

doi:10.3889/oamjms.2022.10461

Authors

Maha Mowafy Department of Family Medicine, Faculty of Medicine (KasrAlainy), Cairo University, Cairo, Egypt
Eman Ahmed Rushdy Department of Internal Medicine, Faculty of Medicine (KasrAlainy), Cairo University, Cairo, Egypt
Maha Rakha Department of Internal Medicine, Faculty of Medicine (KasrAlainy), Cairo University, Cairo, Egypt
Eman Elshekheiby Department of Family Medicine, Cairo University, Cairo, Egypt https://orcid.org/0000-0001-9801-7801
Saeed Soliman Department of Family Medicine, Faculty of Medicine (KasrAlainy), Cairo University, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2022.10461

Keywords:

Subclinical hypothyroidism, Substitution, Quality of life, Glycemic control

Abstract

BACKGROUND: Subclinical hypothyroidism is diagnosed by increased level of serum thyroid-stimulating hormone (TSH) with normal levels of free triiodothyronine (FT3) and free thyroxine (FT4). Controversy exists concerning the early treatment of subclinical hypothyroidism with levothyroxine when TSH level is below 10 mIU/L.

AIM: This stud aims to quantify the effects of a 3-month trial of levothyroxine replacement on quality of life in SCH patients with TSH level less than 10 mIU/L as primary outcome and fasting blood sugar and HbA1C levels as secondary outcome.

METHODS: This was a randomized controlled trial. It was carried out on subjects between 18 and 65 years, of both sexes attending the family medicine outpatient clinic at Cairo University Hospitals with untreated symptomatic mild subclinical hypothyroidism. Simple randomization was performed by assigning random numbers from random number table. Quality of life (Short-Form 36 Questionnaire) as well as fasting blood sugar levels and HbA1C were assessed before the replacement of levothyroxine and 3 months after starting treatment in the subclinical hypothyroidism patients (intervention group) and were compared to the control group.

RESULTS: The median of role limitations due to emotional problems, social functioning, and health change was higher in the intervention group in comparison with the control group. Moreover, the median scores of all general health questionnaire items showed significant positive statistical changes in the intervention group. There was also a significant improvement in glycemic control reflected in lower HbA1C levels and FBS.

CONCLUSION: The results of our study highlight the positive effect of early substitution with levothyroxine in subclinical hypothyroid patients regarding the quality of life and glycemic control in Egypt and support the argument for replacement.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Hennessey JV, Espaillat R. Subclinical hypothyroidism: A historical view and shifting prevalence. Int J Clin Pract. 2015;69(7):771-82. http://doi.org/10.1111/ijcp.12619 PMid:25846327 DOI: https://doi.org/10.1111/ijcp.12619

Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA guideline: Management of subclinical hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. http://doi.org/10.1159/000356507 PMid:24783053 DOI: https://doi.org/10.1159/000356507

Pesic MM, Radojkovic D, Antic S, Kocic R, Stankovic-Djordjevic D. Subclinical hypothyroidism: Association with cardiovascular risk factors and components of metabolic syndrome. Biotechnol Biotechnol Equip. 2015;29(1):157-63. http://doi.org/10.1080/13102818.2014.991136 PMid:26740791 DOI: https://doi.org/10.1080/13102818.2014.991136

Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575-82. http://doi.org/10.1210/jc.2007-1499 PMid:17911171 DOI: https://doi.org/10.1210/jc.2007-1499

Pyati A, Dhuttargi S, Das D, Shetkar NR. Assessment of the cardiovascular risk in subclinical hypothyroidism. Int J Pharm Biol Sci. 2012;2(2):128-34.

Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr Pract. 2012;18(6):988-1028. http://doi.org/10.4158/EP12280.GL PMid:23246686 DOI: https://doi.org/10.4158/EP12280.GL

Pandrc MS, Ristić A, Kostovski V, Stanković M, Antić V, Milin-Lazović J, et al. The effect early substitution subclinical hypothyroidism on biochemical blood parameters quality life. J Med Biochem 2017;36:127-36. DOI: https://doi.org/10.1515/jomb-2017-0007

Skarulis M, Celi F, Mueller E, Zemskova M, Malek R, Hugendubler L. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab 2010;95:256-62. DOI: https://doi.org/10.1210/jc.2009-0543

Kompaniyets L, Goodman A, Belay B, Freedman D, Sucosky MS, Lange SJ, et al. Body mass index and risk for covid-19 related hospitalization, intensive care unit admission, invasive mechanical ventilation-death United States. MMWR Morb Mortal Wkly Rep. 2021;70(10):355-61. http://doi.org/10.15585/mmwr.mm7010e4 PMid:33705371 DOI: https://doi.org/10.15585/mmwr.mm7010e4

Reuters VS, de Paiva Almeida C, de Fátima dos Santos Teixeira P, dos Santos Vigário P, Ferreira MM, de Castro CL, et al. Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq Bras EndocrinolMetab. 2012;56(2):128-36. DOI: https://doi.org/10.1590/S0004-27302012000200006

Guermazi M, Allouch C, Yahia M, Huissa TB, Ghorbel S, Damak J, et al. Translation in Arabic, adaptation and validation of the SF-36 health survey for use in Tunisia. Ann Phys Rehabil Med. 2012;55(6):388-403. http://doi.org/10.1016/j.rehab.2012.05.003 PMid:22795246 DOI: https://doi.org/10.1016/j.rehab.2012.05.003

Basta I, Pekmezovi T, Padua L, Stojanovi V, Stevi Z, Nikoli A, et al. Validation of Serbian version of the disease-specific myasthenia gravis questionnaire. Acta Neurol Scand. 2010;122(2):110-4. http://doi.org/10.1111/j.1600-0404.2009.01269.x PMid:20003082 DOI: https://doi.org/10.1111/j.1600-0404.2009.01269.x

Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res. 2007;16:1053-63. http://doi.org/10.1007/s11136-007-9209-1 PMid:17516149 DOI: https://doi.org/10.1007/s11136-007-9209-1

Miller MC, Knapp RG. Clinical Epidemiology and Biostatistics. 3rd ed. Maryland: Lippincott Williams and Wilkins; 1992.

Biondi B. Thyroid and obesity: An intriguing relationship. J Clin Endocrinol Metab. 2010;95(8):3614-7. http://doi.org/10.1210/jc.2010-1245 PMid:20685890 DOI: https://doi.org/10.1210/jc.2010-1245

Baumgartner C, Blum MR, Rodondi N. Subclinical hypothyroidism: Summary of evidence in 2014. Swiss Med Wkly. 2014;144:w14058. http://doi.org/10.4414/smw.2014.14058 PMid:25536449 DOI: https://doi.org/10.4414/smw.2014.14058

Stott DJ, Gussekloo J, Kearney PM, Rodondi N, Westendorp RG, Mooijaart S, et al. Study protocol; thyroid hormone replacement for untreated older adults with subclinical hypothyroidism a randomized placebo controlled trial (TRUST). BMC Endocr Disord. 2017;17(1):6. http://doi.org/10.1186/s12902-017-0156-8 PMid:28158982 DOI: https://doi.org/10.1186/s12902-017-0156-8

Billic- Komarica E. Beciragic A, Junuzovic D. The importance of HbA1c control in patients with subclinical hypothyroidism. Mater Sociomed. 2012;24(4):212-9.Open Access Maced J Med Sci. 2022 Sep 12; 10(B):2098-2103. 2103 DOI: https://doi.org/10.5455/msm.2012.24.212-219